• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

一项关于白内障发展眼中同时进行可植入式角膜胶原晶状体摘除与超声乳化白内障吸除联合人工晶状体植入临床结果的多中心研究。

A Multicenter Study on Clinical Outcomes of Simultaneous Implantable Collamer Lens Removal and Phacoemulsification with Intraocular Lens Implantation in Eyes Developing Cataract.

作者信息

Kamiya Kazutaka, Shimizu Kimiya, Kitazawa Yoshihiro, Kojima Takashi, Nakamura Tomoaki, Ichikawa Kazuo, Fujimoto Kahoko

机构信息

Visual Physiology, School of Allied Health Sciences, Kitasato University, 1-15-1 Kitasato, Minami, Sagamihara, Kanagawa, 252-0373, Japan.

Department of Ophthalmology, Sanno Hospital, Tokyo, Japan.

出版信息

Ophthalmol Ther. 2025 Feb;14(2):337-350. doi: 10.1007/s40123-024-01078-8. Epub 2024 Dec 18.

DOI:10.1007/s40123-024-01078-8
PMID:39692854
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11754574/
Abstract

INTRODUCTION

This study evaluated the clinical outcomes of simultaneous implantable collamer lens (ICL) removal and phacoemulsification with intraocular lens (IOL) implantation in a multicenter study.

METHODS

We retrospectively investigated 83 eyes of 72 patients requiring ICL extraction and cataract surgery at five institutions. Preoperatively and 3 months postoperatively, we determined visual acuity (logMAR), spherical equivalent refraction, and endothelial cell density (ECD), in addition to the preoperative backgrounds and the postoperative complications.

RESULTS

The patients' age at the time of cataract surgery was 49.8 ± 6.8 years, and the axial length was 28.49 ± 1.97 mm. The most prevalent type of cataract was anterior subcapsular cataract, followed by nuclear and cortical cataract. Uncorrected and corrected visual acuities significantly improved to 0.09 ± 0.30 and - 0.12 ± 0.12 logMAR, respectively (p < 0.001). Sixty-three (76%) and 78 (94%) eyes were within ± 0.5 D and 1.0 D, respectively, of the targeted correction. The mean percentage of ECD loss was 1.3 ± 11.3%. No vision-threatening complications were observed in any case.

CONCLUSIONS

Our multicenter study showed that simultaneous ICL removal and phacoemulsification with IOL implantation is a safe, effective, and predictable procedure, with no significant complications, making it a feasible option for ICL-implanted eyes developing cataracts.

摘要

引言

本多中心研究评估了同时进行可植入式胶原晶状体（ICL）摘除及白内障超声乳化吸除联合人工晶状体（IOL）植入术的临床效果。

方法

我们回顾性调查了五家机构中72例需要进行ICL摘除和白内障手术的患者的83只眼。术前及术后3个月，我们测定了视力（logMAR）、等效球镜度、内皮细胞密度（ECD），此外还记录了术前情况和术后并发症。

结果

白内障手术时患者年龄为49.8±6.8岁，眼轴长度为28.49±1.97mm。最常见的白内障类型是前囊下白内障，其次是核性和皮质性白内障。未矫正和矫正视力分别显著提高至0.09±0.30和-0.12±0.12 logMAR（p<0.001）。分别有63只眼（占76%）和78只眼（占多94%）的屈光矫正度数在目标矫正度数±0.5D和1.0D范围内。ECD损失的平均百分比为1.3±11.3%。所有病例均未观察到威胁视力的并发症。

结论

我们的多中心研究表明，同时进行ICL摘除及白内障超声乳化吸除联合IOL植入术是一种安全、有效且可预测的手术，无明显并发症，使其成为植入ICL后发生白内障的眼睛一种可行的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/e5fec6fff39b/40123_2024_1078_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/d864e16da077/40123_2024_1078_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/46dee1a4ecac/40123_2024_1078_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/9fcfb9f04b1f/40123_2024_1078_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/9d58f33a5df6/40123_2024_1078_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/e5fec6fff39b/40123_2024_1078_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/d864e16da077/40123_2024_1078_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/46dee1a4ecac/40123_2024_1078_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/9fcfb9f04b1f/40123_2024_1078_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/9d58f33a5df6/40123_2024_1078_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bc3/11754574/e5fec6fff39b/40123_2024_1078_Fig5_HTML.jpg

相似文献

1
A Multicenter Study on Clinical Outcomes of Simultaneous Implantable Collamer Lens Removal and Phacoemulsification with Intraocular Lens Implantation in Eyes Developing Cataract.一项关于白内障发展眼中同时进行可植入式角膜胶原晶状体摘除与超声乳化白内障吸除联合人工晶状体植入临床结果的多中心研究。
Ophthalmol Ther. 2025 Feb;14(2):337-350. doi: 10.1007/s40123-024-01078-8. Epub 2024 Dec 18.
2
Outcome of simultaneous phakic implantable contact lens removal with cataract extraction and pseudophakic intraocular lens implantation.同时进行有晶状体眼人工晶状体取出与白内障摘除及假晶状体人工晶状体植入的结果。
J Cataract Refract Surg. 2006 Apr;32(4):595-8. doi: 10.1016/j.jcrs.2006.01.025.
3
Incidence of cataract following implantation of a posterior-chamber phakic lens ICL (Implantable Collamer Lens) - long-term results.后房型有晶状体眼人工晶状体（ICL，可植入式胶原晶状体）植入术后白内障的发生率——长期结果。
Cesk Slov Oftalmol. 2017 Fall;73(3):87-93.
4
A case report of implantable collamer lens removal with cataract extraction and TECNIS Symfony extended range of vision intraocular lens (ZXR00) implantation.一例关于取出可植入式胶原晶状体并同时进行白内障摘除及植入TECNIS Symfony扩展视程人工晶状体（ZXR00）的病例报告。
BMC Ophthalmol. 2025 May 7;25(1):276. doi: 10.1186/s12886-025-04106-8.
5
Correction of Myopia and Myopic Astigmatism by Implantation of a Phakic Posterior Chamber Implantable Collamer Lens.通过植入有晶状体后房可植入胶原晶状体矫正近视和近视散光。
Cesk Slov Oftalmol. 2019 Winter;74(4):147-152. doi: 10.31348/2018/1/4-4-2018.
6
Long-term Comparison of Vault and Complications of Implantable Collamer Lens with and without a Central Hole for High Myopia Correction: 5 Years.长期比较植入 Collamer 透镜穹顶和并发症，有中央孔和无中央孔用于高度近视矫正：5 年。
Curr Eye Res. 2022 Apr;47(4):540-546. doi: 10.1080/02713683.2021.2012202. Epub 2021 Dec 12.
7
Successful toric intraocular lens implantation in a patient with induced cataract and astigmatism after posterior chamber toric phakic intraocular lens implantation: a case report.后房型有晶状体眼人工晶状体植入术后诱发白内障和散光患者成功植入散光型人工晶状体：一例报告
J Med Case Rep. 2012 Apr 16;6:109. doi: 10.1186/1752-1947-6-109.
8
Posterior chamber collamer phakic intraocular lens implantation: Comparison of efficacy and safety for low and moderate-to-high myopia.后房可折叠式有晶状体眼人工晶状体植入术：低度与中高度近视的疗效及安全性比较
Eur J Ophthalmol. 2021 Apr 22:11206721211012861. doi: 10.1177/11206721211012861.
9
Clinical outcomes and patient satisfaction after Visian Implantable Collamer Lens removal and phacoemulsification with intraocular lens implantation in eyes with induced cataract.诱导性白内障患者行 Visian 可植入 Collamer 透镜取出联合白内障超声乳化吸除及人工晶状体植入术后的临床疗效和患者满意度。
Eye (Lond). 2010 Feb;24(2):304-9. doi: 10.1038/eye.2009.87. Epub 2009 Apr 24.
10
[Observation on the efficacy of cataract surgery combined with ICL implantation in the contralateral eye for patients with high myopia complicated with monocular cataract].高度近视合并单眼白内障患者白内障手术联合对侧眼ICL植入术的疗效观察
Zhonghua Yan Ke Za Zhi. 2024 Dec 11;60(12):985-990. doi: 10.3760/cma.j.cn112142-20240313-00111.

引用本文的文献

1
Impact of veriflex and ICL on corneal biomechanics and endothelial cell density.Veriflex和有晶体眼人工晶状体对角膜生物力学及内皮细胞密度的影响。
Sci Rep. 2025 Aug 27;15(1):31553. doi: 10.1038/s41598-025-14330-3.

本文引用的文献

1
Visual Outcomes of Cataract Surgery in Patients with Previous History of Implantable Collamer Lens.有可植入式角膜胶原晶状体植入史患者白内障手术的视觉效果
J Clin Med. 2024 Jul 23;13(15):4292. doi: 10.3390/jcm13154292.
2
Endothelial cell loss post-implantable collamer lens V4c: meta-analysis.可植入 Collamer 透镜 V4c 后内皮细胞丢失：荟萃分析。
J Cataract Refract Surg. 2024 Apr 1;50(4):420-423. doi: 10.1097/j.jcrs.0000000000001389.
3
Ten-year follow-up of posterior chamber phakic intraocular lens with central port design in patients with low and normal vault.
低和正常眼后房深度患者的中央孔型后房型有晶状体眼人工晶状体 10 年随访
J Cataract Refract Surg. 2024 May 1;50(5):441-447. doi: 10.1097/j.jcrs.0000000000001379.
4
The effect of implantable collamer Lens V4c on ocular biometric measurements and intraocular lens power calculation based on Pentacam-AXL and IOLMaster 500.基于 Pentacam-AXL 和 IOLMaster 500 的植入 Collamer 透镜 V4c 对眼生物测量和人工晶状体度数计算的影响。
BMC Ophthalmol. 2022 Nov 5;22(1):421. doi: 10.1186/s12886-022-02644-z.
5
Eight-Year Outcomes of Implantation of Posterior Chamber Phakic Intraocular Lens With a Central Port for Moderate to High Ametropia.植入带有中央端口的后房型有晶状体眼人工晶状体治疗中高度屈光不正的八年随访结果
Front Med (Lausanne). 2021 Dec 16;8:799078. doi: 10.3389/fmed.2021.799078. eCollection 2021.
6
Evaluation of impact of posterior phakic IOL implantation on biometry and effectiveness of concomitant use of anterior segment OCT on IOL power calculation for cataract surgery.评估后房型有晶状体眼人工晶状体植入对生物测量和前节 OCT 联合应用对白内障手术 IOL 屈光力计算的影响。
J Cataract Refract Surg. 2022 Jun 1;48(6):657-662. doi: 10.1097/j.jcrs.0000000000000811. Epub 2021 Sep 1.
7
Safety and visual outcomes following posterior chamber phakic intraocular lens bilensectomy.后房型有晶状体眼双透镜人工晶状体切除术的安全性和视觉效果
Eye Vis (Lond). 2020 Jul 1;7:34. doi: 10.1186/s40662-020-00200-8. eCollection 2020.
8
Ten-year clinical outcomes after implantation of a posterior chamber phakic intraocular lens for myopia.后房型有晶状体眼人工晶状体植入治疗近视的 10 年临床效果。
J Cataract Refract Surg. 2019 Nov;45(11):1555-1561. doi: 10.1016/j.jcrs.2019.06.015. Epub 2019 Oct 3.
9
Posterior Chamber Phakic Intraocular Lens Implantation for the Correction of Myopia and Myopic Astigmatism: A Retrospective 10-Year Follow-up Study.后房型有晶状体眼人工晶状体植入术矫正近视及近视散光：10 年回顾性研究。
Am J Ophthalmol. 2019 Oct;206:1-10. doi: 10.1016/j.ajo.2019.04.024. Epub 2019 May 10.
10
Incidence of implantable Collamer lens-induced cataract.人工晶状体 Collamer 诱导性白内障的发生率。
Can J Ophthalmol. 2018 Oct;53(5):518-522. doi: 10.1016/j.jcjo.2017.11.018. Epub 2018 Mar 28.